News
MedPage Today on MSN1d
FDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Q: Did President Donald Trump call military nurse Ruby Bradley a “loser,” and were there orders for her service history to be removed from Department of Defense archives?
Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
MedPage Today on MSN3d
FDA Officials Detail Plan to Limit COVID ShotsThe FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback